BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5732398)

  • 1. [Preliminary results of immunosuppressive treatment in chronic liver diseases].
    Perings E; Hunstein W; Creutzfeldt W
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):209-12. PubMed ID: 5732398
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical course observations of children with chronic aggressive hepatitis and liver cirrhosis during immunosuppressive therapy].
    Jeschke R; Gekle D; Franzen C
    Monatsschr Kinderheilkd (1902); 1980 May; 128(5):261-3. PubMed ID: 7421831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunosuppressive therapy of inflammatory liver diseases].
    Meyer zum Büschenfelde ; Perings E; Crettzfeldt W
    Ther Umsch; 1971 Sep; 28(9):586-95. PubMed ID: 5122521
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
    Bannaski H
    Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive therapy in chronic inflammatory liver diseases].
    Deicher H
    Verh Dtsch Ges Inn Med; 1972; 78():765-7. PubMed ID: 4665750
    [No Abstract]   [Full Text] [Related]  

  • 7. [ -Mercaptopropionylglycine (Thiola) in the treatment of chronic hepatitis].
    Labò G; Barbara L; Gasbarrini G; Roda E; Schiavina M; Bonvicini F
    Minerva Med; 1972 Oct; 63(75):4055-9. PubMed ID: 4563998
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD; Neverov IV; Turitsyna IG; Dement'eva ES; Krylova NI
    Sov Med; 1985; (12):26-30. PubMed ID: 4095626
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of immunoglobulins in the immunosuppressive therapy of liver diseases].
    Bauch K; Zimmermann S; Lewicki I; Büttner W
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2135-7. PubMed ID: 4650683
    [No Abstract]   [Full Text] [Related]  

  • 10. [Functional activity of leukocytes in patients with chronic hepatitis and liver cirrhosis].
    Veprinskaia SI; Radugina GS
    Vrach Delo; 1977 Jun; (6):98-100. PubMed ID: 883293
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunosuppressive drugs in the treatment of liver diseases (author's transl)].
    Magnenat P
    Ther Umsch; 1979 May; 36(5):432-8. PubMed ID: 451956
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of cellular immunity in chronic liver diseases during immunosuppressive treatment.
    Salerno F; Tornaghi G; Cappellini MD; Fargion S; Fiorelli G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:272. PubMed ID: 4851922
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive treatment of chronic hepatitis].
    Magyar I
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):31-4. PubMed ID: 5501423
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indications for treatment of chronic hepatitis and liver cirrhosis and their complications. 1. Treatment of chronic hepatitis and liver cirrhosis].
    Schimmelpfennig W; Wagner K; Schneider G; Zimmermann HB
    Z Arztl Fortbild (Jena); 1974 Jun; 68(11):529-34 contd. PubMed ID: 4373944
    [No Abstract]   [Full Text] [Related]  

  • 15. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis.
    Mistilis SP; Lam KC
    Prog Liver Dis; 1972; 4():419-32. PubMed ID: 4569006
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of progressive chronic hepatitis with intravenous administrations of colloidal iron].
    Fleischer J; Morgenstern D
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):29-30. PubMed ID: 5501422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of immunoglobulins and the histological picture under immunosuppressive therapy in chronic liver diseases].
    Bauch K; Büttner W; Lewicki J; Dempe A; Zimmermann S
    Z Arztl Fortbild (Jena); 1973 Jul; 67(14):705-10. PubMed ID: 4774636
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immediate and long-term effects of therapeutic immunodepression in active chronic hepatitis. Prospective study of the action of prednisone and azathioprine].
    Nicolaescu T; Bittman E; Stoiculescu P; Udrescu E; Bordeianu A; Gheorghe N; Metz L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):371-82. PubMed ID: 6120554
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process].
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L
    Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.